Effects of footshock stress and morphine on natural killer lymphocytes in rats: studies of tolerance and cross-tolerance

Exposure to a form of footshock stress known to cause opioid-mediated analgesia suppresses the cytotoxic activity of natural killer (NK) cells in rats. This suppression is blocked by the opioid antagonist, naltrexone and is mimicked by morphine administration, suggesting mediation by opioid receptors. Supporting this hypothesis, we now report that the morphine-induced suppression of NK activity shows tolerance after 14 daily injections. The NK-suppressive effect of stress, however, shows neither tolerance with repetition nor cross-tolerance in morphine-tolerant rats.

Opioid and non-opioid stress analgesia from cold water swim: importance of stress severity

We have previously reported that stress severity plays an important role in determining the neurochemical basis of stress-induced analgesia from inescapable footshock. Increasing severity (duration or intensity of continuous footshock) causes a shift in mediation of the resultant analgesia from opioid to non-opioid. In this study, we find that stress severity plays a similar role in analgesia from cold water swim. More severe swims (longer duration or lower water temperature) produce stress analgesia insensitive to the opiate antagonist, naltrexone, whereas less severe swims produce analgesia significantly attenuated by this drug.

Two opioid forms of stress analgesia: studies of tolerance and cross-tolerance

We have previously reported that stress analgesia sensitive to and insensitive to opiate antagonists can be differentially produced in rats by varying the severity or temporal pattern of inescapable footshock. In these studies, we give further evidence for the opioid and non-opioid bases of these paradigms of stress analgesia. We find that naloxone-sensitive analgesia demonstrates tolerance with repeated stress and cross-tolerance with morphine, whereas naloxone-insensitive analgesia demonstrates neither of these characteristics. Moreover, different forms of opioid, but not non-opioid, stress analgesia manifest cross-tolerance with each other. These data are discussed in terms of the similarities and differences between two forms of opioid stress analgesia.

Differential effects of scopolamine on 3 forms of stress analgesia

We have previously reported that non-opioid stress analgesia and two forms of opioid stress analgesia can be differentially produced in rats by varying the severity or temporal pattern of inescapable footshock. In this study, we investigated the role of muscarinic cholinergic mechanisms in mediating these 3 forms of stress analgesia. Whereas the muscarinic anticholinergic drug, scopolamine, had no effect on either non-opioid stress analgesia or opioid stress analgesia from 1 min of continuous 2.5-mA footshock, it significantly attenuated opioid analgesia from 20 min of intermittent footshock at this same intensity. The data are discussed in reference to other similarities and differences between these two forms of opioid stress analgesia.

Analgesic, locomotor and lethal effects of morphine in the mouse: strain comparisons

We have compared the analgesic, locomotor stimulatory and lethal effects of morphine in two strains of mice, C57BL/6BY and CXBK. The CXBK strain is known to be deficient in central opioid binding sites and to be less sensitive than the C57 strain to certain effects of morphine and endogenous opioids. We found that the CXBK strain was less sensitive than the C57s to the analgesic and locomotor effects of morphine, but did not significantly differ in regard to morphine's lethal effect. The strain differences in sensitivity to the analgesic and locomotor effects were not uniform. The CXBK strain was much less sensitive than the C57 strain to the analgesic effect but only moderately less sensitive to the locomotor stimulatory effect. These differences may relate to previously demonstrated strain differences in the amounts of mu 1 and mu 2 opioid binding in central nervous system areas thought to mediate these behaviors.

Stimulation-produced and stress-induced analgesia: cross-tolerance between opioid forms

Electrical stimulation of medial brainstem sites produces potent analgesia in rats that is either opioid- or non-opioid-mediated depending on the specific brain region stimulated. Footshock stress also causes opioid and non-opioid forms of analgesia in rats depending on the exact parameters of footshock administered. We now report that opioid, but not non-opioid, stress analgesia demonstrates cross-tolerance with opioid, but not non-opioid, stimulation-produced analgesia. This finding suggests that opioid forms of stimulation-produced and stress-induced analgesia share a common substrate.

Opioid but not nonopioid stress-induced analgesia is enhanced following prenatal exposure to ethanol

Two neurochemically distinct forms of stress-induced analgesia were examined in adult rats following prenatal ethanol exposure. Rats were exposed to ethanol during the last 2 weeks of gestation through a liquid diet presented to the dams. Analgesia testing was conducted when the offspring were 150-210 days of age. Two forms of footshock stress were administered; one that resulted in a naloxone-sensitive (opioid-mediated) analgesia and one that resulted in a naloxone-insensitive (nonopioid) form of analgesia. Rats prenatally exposed to ethanol demonstrated significantly enhanced opioid-mediated analgesia, but unaltered nonopioid analgesia compared to controls. These results confirm previous findings that prenatal exposure to ethanol leads to long-term alterations in responding to some, but not all forms of stress. The possibility that prenatal exposure to ethanol leads to perturbations in the endogenous opioid systems is discussed.

Intrinsic mechanisms of pain inhibition: activation by stress

Portions of the brain stem seem normally to inhibit pain. In man and laboratory animals these brain areas and pathways from them to spinal sensory circuits can be activated by focal stimulation. Endogenous opioids appear to be implicated although separate nonopioid mechanisms are also evident. Stress seems to be a natural stimulus triggering pain suppression. Properties of electric footshock have been shown to determine the opioid or nonopioid basis of stress-induced analgesia. Two different opioid systems can be activated by different footshock paradigms. This dissection of stress analgesia has begun to integrate divergent findings concerning pain inhibition and also to account for some of the variance that has obscured the reliable measurement of the effects of stress on tumor growth and immune function.

Body region shocked need not critically define the neurochemical basis of stress analgesia

Both opioid and non-opioid forms of stress-induced analgesia have been demonstrated in rats, although the conditions leading to their selective activation are still being investigated. We have shown that variations in shock intensity, duration or temporal pattern can determine whether opioid or non-opioid stress analgesia occurs. Others have suggested that body region shocked is the critical determinant, analgesia from front paw shock being opioid and that from hind paw shock non-opioid. We now report that either opioid or non-opioid stress analgesia can be evoked from either front or hind paws depending only on footshock intensity when duration and temporal pattern are held constant.

Activating endogenous opioid systems by electroconvulsive shock or footshock stress inhibits recurrent kindled seizures in rats

Electroconvulsive shock (ECS) significantly decreased the behavioral manifestations of seizures elicited by amygdaloid stimulation in kindled rats. This anticonvulsant effect was significantly reduced by the opiate antagonist, naloxone, and by the development of morphine tolerance. A form of footshock stress known to cause opioid-mediated analgesia had a similar anticonvulsant effect, whereas another form causing non-opioid analgesia did not. These results suggest that the anticonvulsant effects of ECS and stress are mediated by the release of endogenous opioids.

Opioid peptides mediate the suppressive effect of stress on natural killer cell cytotoxicity

The cytotoxic activity of natural killer cells was investigated in rats subjected to one of two inescapable footshock stress paradigms, both of which induce analgesia, but only one via activation of opioid mechanisms. Splenic natural killer cell activity was suppressed by the opioid, but not the nonopioid, form of stress. This suppression was blocked by the opioid antagonist naltrexone. Similar suppression of natural killer activity was induced by high doses of morphine. These results suggest that endogenous opioid peptides mediate the suppressive effect of certain forms of stress on natural killer cell cytotoxicity.

Changes in simple and complex behaviors following kindled seizures in rats: opioid and nonopioid medication

To learn more about postictal behaviors and their underlying mechanisms, five behaviors and EEG recordings were studied following fully generalized, kindled seizures in rats. The behaviors included bar pressing for food; tail withdrawal, squeak, and multiple squeak responses to painful tail shocks; consumption of freely available food; clinging to a vertical grid; and locomotion. Latencies from the end of a seizure afterdischarge until each behavior recovered were compared and were found to cluster in three distinct pairs. Locomotion and grid clinging recovered most quickly; consumption of freely available food and EEG postictal depression recovered next; and bar pressing for food and the multiple squeak response recovered most slowly. Naloxone pretreatment (10 mg/kg but not 1 mg/kg) shortened recovery to multiple squeak responses, grid clinging, and locomotion, without affecting recovery of bar pressing, food consumption, or EEG postictal depression. These results suggest that complex behaviors recover more slowly following a seizure than simple behaviors. It also appears that opioids are released by a kindled seizure and mediate certain postictal changes in motor- and pain-related behaviors.

Apparent involvement of opioid peptides in stress-induced enhancement of tumor growth

Exposure to stress has been associated with alterations in both immune function and tumor development in man and laboratory animals. In the present study, we investigated the effect of a particular type of inescapable footshock stress, known to cause an opioid mediated form of analgesia, on survival time of female Fischer 344 rats injected with a mammary ascites tumor. Rats subjected to inescapable footshock manifested an enhanced tumor growth indicated by a decreased survival time and decreased percent survival. This tumor enhancing effect of stress was prevented by the opiate antagonist, naltrexone, suggesting a role for endogenous opioid peptides in this process. In the absence of stress, naltrexone did not affect tumor growth.

Involvement of central muscarinic cholinergic mechanisms in opioid stress analgesia

Stress has been shown capable of differentially activating opioid- and non-opioid-mediated endogenous analgesia systems. In this study, the muscarinic cholinergic antagonist, scopolamine, but not the centrally inactive methylscopolamine, blocks opioid, but not non-opioid stress analgesia. Additionally, naltrexone, an opiate antagonist, attenuates analgesia induced by oxotremorine, a cholinergic agonist. These findings support the existence of a muscarinic cholinergic synapse in a central nervous system opioid pain-inhibitory pathway.

Evidence for the independence of brainstem mechanisms mediating analgesia induced by morphine and two forms of stress

Exposure to inescapable footshock stress causes potent analgesia in the rat. According to several criteria, prolonged, intermittent footshock elicits analgesia mediated by opioid peptides, whereas brief, continuous footshock produces non-opioid analgesia. We now report that these neurochemically discrete forms of stress analgesia also have different neuroanatomical bases. Electrolytic lesions damaging greater than 85% of the n. raphe magnus ('complete' NRM lesions), but not lesions of the same size causing less NRM damage (partial NRM lesions) significantly reduce only the non-opioid form of stress analgesia. In the same animals, complete and partial NRM lesions disrupt morphine analgesia; however, our analyses indicate that this effect is not mediated by the same substrate involved in either form of stress analgesia. These results support the existence of multiple endogenous analgesia mechanisms and indicate a complex role for the NRM in these systems.

Opioid and non-opioid mechanisms of footshock-induced analgesia: role of the spinal dorsolateral funiculus

Exposure to inescapable footshock causes either an opioid or non-opioid mediated analgesia in the rat depending on the temporal parameters of its administration. Lesions of the spinal dorsolateral funiculus significantly reduce both the opioid and non-opioid forms of this footshock-induced analgesia. Thus, these two neurochemically discrete pain-inhibitory systems appear to depend on the integrity of the same descending path, one known to be activated by morphine and by analgesic brain stimulation.

N. raphe magnus lesions disrupt stimulation-produced analgesia from ventral but not dorsal midbrain areas in the rat

We previously found that the opiate antagonist, naloxone, partially blocks stimulation-produced analgesia (SPA) elicited from ventral but not dorsal regions of the medial midbrain in rats. The present study compares the effects of n. raphe magnus (NRM) lesions on SPA from these same two midbrain areas. SPA thresholds were measured with the tail-flick method and compared before and for up to two weeks after NRM lesions. A high positive correlation was found between percent NRM destruction and percent increase in SPA threshold for rats with ventral but not dorsal electrode placements. Damage to brain areas other than NRM seemed not to contribute to these effects. We conclude that n. raphe magnus is a critical relay in the pain-suppressive path from that area of the rat midbrain mediating an opioid form of stimulation-produced analgesia.

Opioid and non-opioid mechanisms of stress analgesia: lack of cross-tolerance between stressors

Qualitatively different analgesic responses can be evoked in rats by exposure to prolonged, intermittent or brief, continuous footshock stress. These two forms of stress analgesia appear to be mediated by opioid and nonopioid pain-inhibitory substrates, respectively. The present study confirms our previous observation that tolerance develops to only the opioid form of stress analgesia and shows that cross-tolerance does not occur between the opioid and nonopioid forms. These data provide further evidence that independent mechanisms underlie opioid and nonopioid stress analgesia.

The opioid/nonopioid nature of stress-induced analgesia and learned helplessness

Exposure to a variety of stressors produces a subsequent analgesic reaction. This stress-induced analgesia (SIA) is sometimes opioid in nature (reversed by opiate antagonists and cross-tolerant with morphine) and sometimes nonopioid. Both 30 min of intermittent footshock and 60-80 five-sec tailshocks have been shown to produce opioid SIA, whereas 3 min of continuous footshock and 5-40 tailshocks produce nonopioid SIA. We report that both of the opioid SIA procedures produce a learned helplessness effect as assessed by shuttlebox escape acquisition and an analgesia that is reinstatable 24 hr. later. The nonopioid procedures produce neither a learned helplessness effect nor a reinstatable analgesia. It is argued that these data implicate the learning of uncontrollability in the activation of opioid systems.